Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Berger

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Amyloid-related imaging abnormalities in AβPP duplication carriersLudivine Chamard, David Wallon, Alexa Pijoff, et al.
Neurology|November 30, 2016
Mystery Case: CSF-1R mutation is a cause of intracranial cerebral calcifications, cysts, and leukoencephalopathyXavier Ayrignac, Kevin Mouzat, Eloi Magnin, et al.
Neurocase|August 31, 2012
Transient improvement in sensorimotor conversion during post-anoxic encephalopathy with bilateral medial temporal ischemiaEloi Magnin, Yavor Delchev, Gilles Chopard, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Spectrum Effect and Spectrum Bias in the Screening Test Performance for Amnestic Mild Cognitive Impairment: What are the Clinical Implications?Gilles Chopard, Marc Puyraveau, Mickael Binetruy, et al.
Clinical Rehabilitation|June 2, 2020
Memory improvement in multiple sclerosis after an extensive cognitive rehabilitation program in groups with a multicenter double-blind randomized trialHelene Brissart, Abdou Y Omorou, Natacha Forthoffer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 19, 2012
Validation of a new quality of life scale related to multiple sclerosis and relapsesAntoine Baroin, Gilles Chopard, Gaye Siliman, et al.
Nanobiomedicine|June 27, 2018
Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophagesEric Berger, Dalibor Breznan, Sandra Stals, et al.
European Neurology|November 25, 2003
Impact of emergency room neurologists on patient management and outcomeThierry Moulin, Denis Sablot, Elisabeth Vidry, et al.
European Neurology|December 5, 2014
Angelman syndrome: a case series assessing neurological issues in adulthoodMarie Giroud, Benoît Daubail, Norbert Khayat, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Amyloid-related imaging abnormalities in AβPP duplication carriersLudivine Chamard, David Wallon, Alexa Pijoff, et al.
Neurology|November 30, 2016
Mystery Case: CSF-1R mutation is a cause of intracranial cerebral calcifications, cysts, and leukoencephalopathyXavier Ayrignac, Kevin Mouzat, Eloi Magnin, et al.
Neurocase|August 31, 2012
Transient improvement in sensorimotor conversion during post-anoxic encephalopathy with bilateral medial temporal ischemiaEloi Magnin, Yavor Delchev, Gilles Chopard, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Spectrum Effect and Spectrum Bias in the Screening Test Performance for Amnestic Mild Cognitive Impairment: What are the Clinical Implications?Gilles Chopard, Marc Puyraveau, Mickael Binetruy, et al.
Clinical Rehabilitation|June 2, 2020
Memory improvement in multiple sclerosis after an extensive cognitive rehabilitation program in groups with a multicenter double-blind randomized trialHelene Brissart, Abdou Y Omorou, Natacha Forthoffer, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 19, 2012
Validation of a new quality of life scale related to multiple sclerosis and relapsesAntoine Baroin, Gilles Chopard, Gaye Siliman, et al.
Nanobiomedicine|June 27, 2018
Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophagesEric Berger, Dalibor Breznan, Sandra Stals, et al.
European Neurology|November 25, 2003
Impact of emergency room neurologists on patient management and outcomeThierry Moulin, Denis Sablot, Elisabeth Vidry, et al.
European Neurology|December 5, 2014
Angelman syndrome: a case series assessing neurological issues in adulthoodMarie Giroud, Benoît Daubail, Norbert Khayat, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Pageof 13